Skip to main content
OpenTrials
Completed

NCT Number: NCT00243438

DaVinci Registry(Distinctly Assess Vision in Coronary Intervention)

Prospective Internet-Registry, Postmarketing-Surveillance, Registration and Follow-up of patients after Multi-Link VISION™ - Stent Implantation

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Kerckhoff-Klinik

Bad Nauheim, 61231, Germany

About this study

A Non-Randomized prospective evaluation of the Multi-Link Rx Vision TM Coronary Stent System in the treatment of patients with De novo native coronary artery lesions

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women and Men Age >18 years, Intention to treat all stenosis with Multi-Link VisionTM Stents, documented patient consent

Exclusion criteria

  • No Multi-Link Vision™ Stent implanted, life expectation >9 M, cardiogenic shock, STEMI, NSTEMI or unstable angina pectoris with pathologic markers within the last 48 hours, intolerance of Clopidogrel/ Tiklopidin

Treatment and study plan

Multilink Vision™ Stent (CE-labeled)

Device

Patients who have diabetes and/or complex lesions and who have had a Multilink Vision™ Stent placed.

Primary outcomes

  1. TVF

    Time frame: 9 months

Secondary outcomes

  1. Mode of death

  2. Time to first MI

  3. TVR

  4. CABG

Sponsors and collaborators

Lead sponsor

Abbott Medical Devices

Industry

Registry information

Official study title

Distinctly Access Vision In Coronary Interventions

Important dates

Study start
2003
Primary completion
2005
Study completion
2005
First posted
Oct 24, 2005
Registry last updated
Jan 28, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.